During the past decade, Universitaetsklinkum Koeln, CF-Studienzentrum conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitaetsklinkum Koeln, CF-Studienzentrum" are "Cystic Fibrosis" (8 trials). Many other conditions were trialed in "Universitaetsklinkum Koeln, CF-Studienzentrum" in a lesser frequency.

Most popular intervention types in "Universitaetsklinkum Koeln, CF-Studienzentrum" are "Drug" (8 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "IVA" (8 trials), "ELX/TEZ/IVA" (6 trials), "Placebo (matched to ELX/TEZ/IVA)" (2 trials), "Placebo (matched to IVA)" (2 trials) and "TEZ/IVA" (2 trials). Other intervention names were less common.

The vast majority of trials in "Universitaetsklinkum Koeln, CF-Studienzentrum" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Universitaetsklinkum Koeln, CF-Studienzentrum". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Universitaetsklinkum Koeln, CF-Studienzentrum, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Universitaetsklinkum Koeln, CF-Studienzentrum, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".